The Tacx Alpine is a $1,100 gradient simulator for your Garmin smart bike trainer
In those same apps, the Tacx Alpine also allows for real-time virtual steering adjustments. Naturally, Garmin Connect support is also included for stat tracking and more. In short, the Tacx Alpine is designed for those who want spice up their off-season training since pedaling a road bike on an indoor trainer is about the most boring thing ever.
Garmin says mounting the front of your bike is easy. Inside the box, you'll find adapters for both quick release skewers (9 x 100), and thru axles (12 x 100, 15 x 100 and 15 x 110), so the Tacx Alpine will work with most modern road bikes. However, trainer compatibility is limited to Garmin's NEO 2T and Neo 3M models. Those cost $1,400 and $2,000 new respectively, and the accessory itself will set you back $1,100, with Garmin not planning to offer bundles at launch.
That might seem like a lot to pay for an accessory designed to make your indoor rides less monotonous, but it's broadly comparable with the rest of the industry. Wahoo, for instance, sells its Kickr Climb simulator for $750, but it doesn't come with a steering feature. Meanwhile, the Elite Rizer, which offers both steering and gradient simulation, costs $1,000. Either way, if you're looking at one of these, chances are you already spent a pretty penny on a fancy carbon road bike and the thought of dropping another $1,000 on your hobby doesn't phase you. If you buy something through a link in this article, we may earn commission.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
14 hours ago
- USA Today
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards
NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / New to The Street, the nation's premier financial media platform for emerging public companies, proudly announces a major media partnership with NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI). Under this agreement, NeOnc will be featured in a 12-part national broadcast series, with exclusive monthly interviews airing on Bloomberg Television and Fox Business Network. The series will also include earned media distribution, commercial rotation across national networks, and outdoor billboard campaigns in the most visible financial corridors in the U.S. This partnership launches at a pivotal time for NeOnc Technologies, following two significant corporate milestones: The signing of a Letter of Intent to acquire breakthrough intellectual property (IP) for brain cancer treatment , positioning the company at the forefront of neuro-oncology innovation; The execution of a $50 million definitive strategic partnership with Quazar Investment, accelerating NeOnc's operational and clinical development roadmap. Breakthrough Science Meets Breakthrough Exposure The integrated media campaign includes: 12 Long-Form Network Broadcast Interviews from the Nasdaq and NYSE studios on Bloomberg TV and Fox Business as sponsored programming. More than 300 Monthly Commercial Spots across targeted investor and innovation-focused time blocks. Earned Media Coverage on major U.S. networks via NewsOut™, including CBS, NBC, and ABC affiliates. Iconic Billboard Placements in Times Square (Nasdaq Tower and Reuters Boards), NYC Financial District shelters, and premium taxi tops. Digital Amplification via YouTube and social platforms: New to The Street TV Channel : NewsOut Channel : Executive Commentary 'NeOnc is entering a new era, not only in terms of medical science but also visibility in the public markets. Their latest IP acquisition and $50 million partnership with Quazar reflect serious momentum,' said Vince Caruso, Founder and CEO of New to The Street. 'We're proud to provide a media platform that matches their global ambitions and innovations with real-world distribution, every month.' About NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on the development and commercialization of central nervous system therapeutics that are designed to address the persistent challenges in overcoming the blood-brain barrier. The company's NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas. NeOnc's lead therapeutics, NEO100™ and NEO212™, are currently in Phase II human clinical trials and advancing under FDA Fast-Track and Investigational New Drug (IND) status. The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California, consisting of issued patents and pending applications related to NEO100, NEO212, and other candidates from the NeOnc patent family for multiple uses, including oncological and neurological conditions. To learn more, visit About New to The Street Since 2009, New to The Street has been a leading force in financial media, showcasing public and private companies through its unmatched mix of national television broadcasts, digital syndication, and social media reach. With over 3.2 million subscribers on the New to The Street TV YouTube channel and a combined following of more than 511,000 across LinkedIn, Facebook, Instagram, and X, the platform delivers consistent visibility to investors, industry leaders, and the general public. New to The Street offers more linear 'real TV' broadcast distribution than any other outlet in the space, with long-running placements across Bloomberg TV, Fox Business Network, and other national platforms. Its 'Opportunities to Consider™' segments and in-depth executive interviews have become a trusted source for market-moving narratives, emerging growth stories, and thought leadership across finance, tech, biotech, and beyond. Learn more: Media Contact: Monica Brennan Head of Communications, New to The Street Monica@ SOURCE: New To The Street View the original press release on ACCESS Newswire
Yahoo
20 hours ago
- Yahoo
Garmin Ltd (GRMN) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Acquisitions ...
Consolidated Revenue: Increased 20% to over $1.8 billion, a new second quarter record. Gross Margin: Expanded to 58.8%. Operating Margin: Expanded to 26%. Operating Income: Reached $472 million, up 38% year-over-year. Pro Forma EPS: $2.17, up 37% year-over-year. Fitness Segment Revenue: Increased 41% to $605 million. Outdoor Segment Revenue: Increased 11% to $490 million. Aviation Segment Revenue: Increased 14% to $249 million. Marine Segment Revenue: Increased 10% to $299 million. Auto OEM Segment Revenue: Increased 16% to $170 million. Free Cash Flow: $127 million, a $91 million decrease from the prior year quarter. Cash and Marketable Securities: Approximately $3.9 billion at quarter end. Inventory: Increased to approximately $1.8 billion. Capital Expenditures: Approximately $46 million for the second quarter. Dividends Paid: Approximately $173 million. Share Repurchase: $67 million of company stock purchased. Effective Tax Rate: 16.5%, down from 17.9% in the prior year quarter. Full Year Revenue Guidance: Updated to approximately $7.1 billion. Full Year Pro Forma EPS Guidance: Updated to approximately $8 per share. Warning! GuruFocus has detected 7 Warning Sign with GRMN. Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Garmin Ltd (NYSE:GRMN) reported a 20% increase in consolidated revenue, reaching a new second quarter record of over $1.8 billion. The company experienced double-digit sales growth across all business segments, with the fitness segment leading at 41% growth. Gross and operating margins expanded to 58.8% and 26%, respectively, resulting in a record second quarter operating income of $472 million, up 38% year-over-year. Garmin Ltd (NYSE:GRMN) announced the acquisition of MYLAPS, which is expected to enhance their offerings in timing and performance analysis for athletic events. The company raised its full-year revenue guidance to approximately $7.1 billion and pro-forma EPS to $8 per share, reflecting strong performance and demand for its products. Negative Points Operating expenses increased by 14%, driven by higher personnel-related costs in research and development and SG&A. Free cash flow decreased by $91 million compared to the prior year quarter, primarily due to an increase in inventory. The auto OEM segment reported an operating loss of $10 million, despite revenue growth. The company faces potential unfavorable impacts from foreign currency fluctuations, particularly the strengthening of the Taiwan dollar. Despite strong revenue growth, the implied second half growth for operating profit dollars is expected to be flat, indicating potential challenges in maintaining leverage. Q & A Highlights Q: Can you explain the strong performance in the fitness segment and any potential influences from channel fill or demand pull forward? A: Clifton Pemble, President and CEO, stated that while there is always some channel fill impact with new product launches, it was not a significant factor in driving outperformance. There is no evidence of demand pull forward, as retailers are cautious with inventory and have credit limits. The channel is well managed, and there are no signs of stockpiling. Q: Regarding the full-year outlook, why is operating profit expected to be flat despite revenue and gross profit growth? A: Douglas Boessen, CFO, explained that operating expenses are expected to increase due to headcount, infrastructure growth, foreign currency impacts, the MYLAPS acquisition, increased performance-based compensation, and co-op advertising. Tariff estimates are lower, but foreign currency impacts will offset this in gross margins. Q: Is Garmin entering a new higher revenue growth paradigm, especially with auto OEM as a tailwind? A: Clifton Pemble noted that Garmin has evolved significantly over the past decade, particularly in the wearable market. The company sees opportunities across all segments and aims to create unique products that lead in existing and new categories. Garmin is optimistic about future growth and continues to invest in innovation. Q: What opportunities does Garmin see with the MYLAPS acquisition? A: Clifton Pemble highlighted that MYLAPS specializes in timing for competitive events, aligning with Garmin's interests in running, triathlon, and cycling. The acquisition allows Garmin to integrate training and race day experiences, providing a comprehensive solution for users. Q: How is Garmin addressing the potential of smart wearables in health management? A: Clifton Pemble expressed excitement about the role of wearables in health management. Garmin offers a diverse product line with advanced sensor measurements and health metrics, providing significant opportunities in helping users manage their health effectively. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Why Garmin Stock Sank After Earnings Today
Key Points Garmin's fitness products drove sales growth with a 41% year-over-year jump. After a 20% rise in overall revenue last year, Garmin sees another 13% coming in 2025. Even with the good news, Garmin shares look a little too pricey for some investors. 10 stocks we like better than Garmin › Global Positioning System (GPS) technology company Garmin (NYSE: GRMN) reported strong second-quarter earnings today and raised full-year guidance. It posted double-digit revenue gains in all five of its business segments. Yet Garmin shares plunged as much as 8% on the news. As of 11:37 a.m. ET, the stock rebounded a bit but was still lower by 5.5%. With the company's sound and growing underlying business, the stock drop today may be an opportunity for investors. Garmin's fitness category wins the race Garmin reported a remarkable 41% revenue jump in its fitness segment. Management noted "strong demand for advanced wearables" driving fitness product sales. That led to an overall 20% revenue increase, compared to the year-ago period. Growth in adventure watches led its outdoor segment, while aviation, marine, and automotive sales also grew nicely. The results led Garmin to increase its 2025 outlook for both sales and earnings per share (EPS). The new sales guidance would represent a 13% surge in revenue in 2025 after reporting 20% annual growth last year. EPS guidance moved from $7.80 to $8 per share. Solid balance sheet Cash flow was strong enough for the company to maintain a pristine balance sheet, even while paying its quarterly dividend and buying back shares in the second quarter. Cash and marketable securities remained at about $3.9 billion as of the end of Q2, with no debt. That represents 9% of Garmin's market cap. Even with all that positive news, shares dropped today, as some investors took advantage of a recent surge in Garmin stock. Shares have jumped by more than 30% since early April, including today's drop. It's not surprising that some investors wanted to lock in those gains. However, the business is firing on all cylinders and the future looks bright. Long-term investors should consider taking advantage of today's pullback by adding Garmin to their portfolios. Do the experts think Garmin is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Garmin make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,039% vs. just 182% for the S&P — that is beating the market by 856.77%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $630,291!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,075,791!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Howard Smith has positions in Garmin and has the following options: short September 2025 $260 calls on Garmin. The Motley Fool has positions in and recommends Garmin. The Motley Fool has a disclosure policy. Why Garmin Stock Sank After Earnings Today was originally published by The Motley Fool Sign in to access your portfolio
